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Background: The increased use of continuous-flow left ventricular assist devices (LVAD) in advanced heart failure has led to marked changes 
in the management of this condition. However, secondary aortic insufficiency (AI) can become a significant complication. This study reports a 
percutaneous, transcatheter therapy to treat AI.
Methods: 5 patients with continuous-flow LVADs and severe post-LVAD AI underwent percutaneous transcatheter AV closure between September to 
October 2011 at a single quaternary care academic medical center. All patients had LVAD inserted as destination therapy. 4 were male, the average 
age was 52 and 40% had an LVAD placed for ischemic cardiomyopathy. LVAD parameters, hemodynamics, and echocardiographic measurements 
were obtained before and after AV closure. 
Results: All patients underwent successful closure with the Amplatzer Cribiform device via a femoral approach. In all patients, AI was reduced from 
severe (4+) to trivial. Pulmonary capillary wedge pressure (PCWP) was significantly reduced from a mean of 32 mmHg to 27 mmHg after closure 
(p=0.005). There was no change in mitral or tricuspid regurgitation, LV function, or LVAD power or pulsatility index. 
Conclusions: Percutaneous transcatheter closure of the aortic valve effectively treats LVAD associated AI without increasing TR and reduces PCWP. 
This procedure should be considered an effective treatment alternative to open surgical repair of LVAD associated AI. Further data is needed to 
assess long-term results.
 
